Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 26

    1.

    Update on anal fistulae: surgical perspectives for the gastroenterologist.

    Tabry H, Farrands PA.

    Can J Gastroenterol. 2011 Dec;25(12):675-80. Review.

    PMID:
    22175058
    [PubMed - indexed for MEDLINE]
    2.

    Autophagy: a primer for the gastroenterologist/hepatologist.

    Sokollik C, Ang M, Jones N.

    Can J Gastroenterol. 2011 Dec;25(12):667-74. Review.

    PMID:
    22175057
    [PubMed - indexed for MEDLINE]
    3.

    Medical management of inflammatory bowel disease among Canadian gastroenterologists.

    Jones J, Panaccione R, Russell ML, Hilsden R.

    Can J Gastroenterol. 2011 Oct;25(10):565-9.

    PMID:
    22059162
    [PubMed - indexed for MEDLINE]
    4.

    What made Canada become a country with the highest incidence of inflammatory bowel disease: could sucralose be the culprit?

    Qin X.

    Can J Gastroenterol. 2011 Sep;25(9):511. No abstract available.

    PMID:
    21912763
    [PubMed - indexed for MEDLINE]
    5.

    Health care resource use and costs in Crohn's disease before and after infliximab therapy.

    Loomes DE, Teshima C, Jacobs P, Fedorak RN.

    Can J Gastroenterol. 2011 Sep;25(9):497-502.

    PMID:
    21912761
    [PubMed - indexed for MEDLINE]
    6.

    Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: a meta-analysis.

    Binion DG, Louis E, Oldenburg B, Mulani P, Bensimon AG, Yang M, Chao J.

    Can J Gastroenterol. 2011 Sep;25(9):492-6.

    PMID:
    21912760
    [PubMed - indexed for MEDLINE]
    7.

    Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial.

    Panaccione R, Loftus EV Jr, Binion D, McHugh K, Alam S, Chen N, Guerette B, Mulani P, Chao J.

    Can J Gastroenterol. 2011 Aug;25(8):419-25.

    PMID:
    21912766
    [PubMed - indexed for MEDLINE]
    8.

    Hepatosplenic lymphoma presenting initially as hemophagocytic syndrome in a 21-year-old man with Crohn's disease: a case report and literature review.

    Côté-Daigneault J, Bernard EJ.

    Can J Gastroenterol. 2011 Aug;25(8):417-8. Review. No abstract available.

    PMID:
    21912765
    [PubMed - indexed for MEDLINE]
    9.

    Estimating benefits of therapy in Crohn's disease in terms of indirect costs.

    Ghosh S.

    Can J Gastroenterol. 2011 Aug;25(8):412. No abstract available.

    PMID:
    21912764
    [PubMed - indexed for MEDLINE]
    10.

    Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases.

    Schicho R, Storr M.

    Can J Gastroenterol. 2011 Jul;25(7):377-83. Review.

    PMID:
    21876860
    [PubMed - indexed for MEDLINE]
    11.

    Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: Controversy resolution requires the patient perspective, not the clinician perspective.

    Kuenstner JT.

    Can J Gastroenterol. 2011 Jun;25(6):297-8; author reply 298. No abstract available.

    PMID:
    21766085
    [PubMed - indexed for MEDLINE]
    12.

    Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts.

    Bernstein CN, El-Gabalawy H, Sargent M, Landers C, Rawsthorne P, Elias B, Targan SR.

    Can J Gastroenterol. 2011 May;25(5):269-73.

    PMID:
    21647462
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Predicting, treating and preventing postoperative recurrence of Crohn's disease: the state of the field.

    Borowiec AM, Fedorak RN.

    Can J Gastroenterol. 2011 Mar;25(3):140-6. Review.

    PMID:
    21499578
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Ethnic variation in the annual rates of adult inflammatory bowel disease in hospitalized patients in Vancouver, British Columbia.

    Mangat BK, Evaschen C, Lee T, Yoshida EM, Salh B.

    Can J Gastroenterol. 2011 Feb;25(2):73-7.

    PMID:
    21321677
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    How well does the Internet answer patients' questions about inflammatory bowel disease?

    Promislow S, Walker JR, Taheri M, Bernstein CN.

    Can J Gastroenterol. 2010 Nov;24(11):671-7.

    PMID:
    21157582
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.
    17.

    Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: a review of the controversy from the clinician's perspective.

    Rosenfeld G, Bressler B.

    Can J Gastroenterol. 2010 Oct;24(10):619-24. Review.

    PMID:
    21037992
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    IBD 2009: emerging research frontiers on the path to a cure.

    Steinhart AH, Tolomiczenko G.

    Can J Gastroenterol. 2010 Sep;24(9):557-65.

    PMID:
    21152461
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    The safety of infliximab infusions in the community setting.

    Ducharme J, Pelletier C, Zacharias R.

    Can J Gastroenterol. 2010 May;24(5):307-11.

    PMID:
    20485705
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Replication and meta-analysis of 13,000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn's disease.

    Cotterill L, Payne D, Levinson S, McLaughlin J, Wesley E, Feeney M, Durbin H, Lal S, Makin A, Campbell S, Roberts SA, O'Neill C, Edwards C, Newman WG.

    Can J Gastroenterol. 2010 May;24(5):297-302. Review.

    PMID:
    20485703
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk